-
Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
Lieuwe de Haan, MD, PhD, Britt Hoogeboom, MD, Nico Beuk, MD, Luuk Wouters, Peter M.A.J. Dingemans, PhD, and Don H. Linszen, MD, PhD
-
Androgens and the Aging Male
By Stuart N. Seidman, MD
-
Primary Sexual Disorders: Recognition and Treatment
By Paula L. Hensley, MD, and Carol K. Slonimski, PhD
-
Gender and Schizophrenia
By Carla M. Canuso, MD and Gahan Pandina, PhD
-
Genetics of Schizophrenia: Recent Advances
By Amy Eisener, BS, Michele T. Pato, MD, Helena Medeiros, MSW, Celia Carvalho, MS, and Carlos N. Pato, MD
-
Neuropsychiatric Update: Neuroimaging Schizophrenia
By Shawn J. Kile, MD
-
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
By Laura B. Dunn, MD
-
Genetics and Its Use in Alzheimer’s Disease
Joseph H. Lee, DRPH and Richard Mayeux, MD, MSC
-
Psychosocial Interventions for Bipolar Disorder: A Review of Literature and Introduction of the Systematic Treatment Enhancement Program
David J. Miklowitz, PhD and Michael W. Otto, PhD
-
The Emergence of the Bipolar Spectrum: Validation along Clinical-Epidemiologic and Familial-Genetic Lines
Hagop S. Akiskal, MD
-
Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects
Jeffrey L. Cummings, MD and Dilip V. Jeste, MD
-
Cognitive Behavioral Approaches to the Treatment of Pain
Sandra J. Waters, PhD, Daphne C. McKee, PhD, and Francis J. Keefe, PhD
-
Invited Commentary: Understanding the Fibromyalgia Syndrome
I. Jon Russell, MD, PhD. and Christopher J. Wohlberg, MD, PhD
-
Evidence-Based Treatment of Psychiatric Disorders with Comorbid Medical Illnesses: The Need for Large Simple Clinical Trials
Warren D. Taylor, MD, P. Murali Doraiswamy, M.B.,B.S., and K. Ranga R. Krishnan, M.B.,B.S
-
Panel Discussion
-
Drug Development for Anxiety Disorders: New Roles for Atypical Antipsychotics
By William H. Carson, MD, Hisashi Kitagawa, PhD, and Charles B. Nemeroff, MD, PhD
-
Unmet Needs in the Treatment of Anxiety Disorders
By Mark H. Pollack, MD
-
Late-Life Anxiety Disorders
By Carl Salzman, MD
-
Understanding Psychiatric Disorders Through Functional Brain Imaging
By Clinton D. Kilts, PhD
-
Early-Life Adversity, CRF Dysregulation, and Vulnerability to Mood and Anxiety Disorders
By Charles B. Nemeroff, MD, PhD
-
Studying Non-Human Primates: A Gateway to Understanding Anxiety Disorders
By Ned H. Kalin, MD
-
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
By Charles B. Nemeroff, MD, PhD
-
-
FEATURE ARTICLE
Understanding The Fibromyalgia Syndrome
Srinivas G. Rao, MD, PhD, Judith F. Gendreau, MD, and Jay D. Kranzler, MD, PhD
-
Valproate Use in Neuropsychiatric Disorders in the Elderly
By Pierre N. Tariot, MD
-
Divalproex in the Treatment of Migraine
By Frederick G. Freitag, DO
-
The Use of Divalproex in the Treatment of Addictive Disorders
By Hugh Myrick, MD and Kathleen T. Brady, MD, PhD
-
Schizophrenia and Valproate
By Leslie Citrome, MD, MPH
